Clear answers on CSV, CSA, Part 11, audit readiness, validation evidence, and how VLMS helps regulated teams move faster without weakening compliance.
VLMS Software is a validation lifecycle management offering for regulated life sciences teams. It combines a structured platform model with expert validation support so teams can manage requirements, risk, testing, traceability, SOPs, deviations, release evidence, and audit packages in one operating rhythm.
A repository stores files. VLMS is designed around validation decisions: what system is in scope, what risk exists, what evidence proves control, what changed, what deviations remain open, and what package an auditor or QA leader needs to see.
Yes. Teams can keep approved SOPs, protocol templates, naming conventions, and evidence formats. The goal is to standardize the lifecycle without forcing a brand reset or unnecessary procedural churn.
Usually no. VLMS can complement an eQMS by organizing validation-specific work and evidence. Change control, CAPA, training, and document approval can remain in your existing QMS while VLMS keeps validation execution traceable.
Yes. VLMS supports URS, functional requirements, configuration specifications, IQ, OQ, PQ, UAT, traceability, deviation logs, and validation summary reports for regulated computerized systems.
Yes. CSA is treated as a risk-based assurance model. We help teams define intended use, identify critical thinking points, focus testing on patient safety/product quality/data integrity risk, and document why the approach is appropriate.
Yes. We support vendor qualification, supplier assessment, release impact review, configurable feature risk, audit trail expectations, access-control review, and periodic review for SaaS systems used in GxP processes.
Yes. Managed validation support can cover protocol authoring, test script preparation, evidence review, execution support, deviation triage, trace matrix maintenance, and final report assembly.
VLMS content and workflows are built around Part 11 expectations such as user access, audit trail review, electronic records, electronic signatures where applicable, system controls, validation evidence, and procedural governance.
Annex 11 expectations are supported through risk management, supplier assessment, validation documentation, data integrity controls, security/access governance, change control, periodic evaluation, and incident/deviation handling.
ALCOA+ is treated as a design principle for evidence. Records should be attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available for inspection.
Yes. We help assemble auditor-ready packages that include scope, intended use, risk rationale, protocol evidence, traceability, deviations, approvals, release decision, SOP references, and outstanding lifecycle commitments.
VLMS is intentionally both. Competitors often sell either software or consulting hours. VLMS is structured to give teams a platform, validation specialists, templates, and operating discipline in one engagement.
Common systems include LIMS, QMS, ERP, MES, eTMF, CTMS, LMS, document management, laboratory instruments, clinical platforms, manufacturing systems, spreadsheets, integrations, and GxP SaaS tools.
Yes. A readiness sprint can identify weak evidence, missing approvals, incomplete traceability, poor risk rationale, stale periodic reviews, open deviations, and unsupported Part 11 assumptions before an inspection.
VLMS is positioned for pharma, biotech, medical devices, CDMOs, CMOs, CROs, laboratories, clinical operations, quality teams, and GxP software vendors.
Send the problem. We will help you identify the fastest path to a defensible validation package.